Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

ENDRA Life Sciences: Q2 Earnings Insights

  ENDRA Life Sciences (NASDAQ:NDRA) reported its Q2 earnings results on Monday, August 15, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
byBenzinga Insights
August 15, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

 

ENDRA Life Sciences (NASDAQ:NDRA) reported its Q2 earnings results on Monday, August 15, 2022 at 04:00 PM.

Here’s what investors need to know about the announcement.

Earnings

ENDRA Life Sciences missed estimated earnings by 20.0%, reporting an EPS of $-0.06 versus an estimate of $-0.05.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.0 which was followed by a 0.51% increase in the share price the next day.

 

To track all earnings releases for ENDRA Life Sciences visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Earnings Preview: Seres Therapeutics

By Benzinga Insights
August 2, 2:41 PM
Seres Therapeutics (NASDAQ:MCRB) is set to give its latest quarterly earnings report on Wednesday, 2022-08-03. Here's what investors need to know before the announcement. Analysts estimate that Seres Therapeutics will report an earnings per share (EPS) of $-0.60.

MCRB

Read More

Amicus Therapeutics Reports Preliminary 2023 Revenue And Provides 2024 Strategic Outlook; Q4 Revenue ~$115.1M Vs $112.25M Est.; Sees FY23 Revenue Of ~$399.4M Vs $396.45M Est.; Co Sees FY24 As First Full Year Of Achieving Non-GAAP Profitability

By Benzinga Newsdesk
January 7, 6:38 PM
Bradley Campbell, President and Chief Executive Officer of Amicus Therapeutics, Inc., stated, "Last year was an incredible year for Amicus highlighted by the continued double-digit growth of Galafold sales and the global

FOLD